Page last updated: 2024-09-03

mdl 73404 and ascorbic acid

mdl 73404 has been researched along with ascorbic acid in 1 studies

Compound Research Comparison

Studies
(mdl 73404)
Trials
(mdl 73404)
Recent Studies (post-2010)
(mdl 73404)
Studies
(ascorbic acid)
Trials
(ascorbic acid)
Recent Studies (post-2010) (ascorbic acid)
200045,2612,49711,176

Protein Interaction Comparison

ProteinTaxonomymdl 73404 (IC50)ascorbic acid (IC50)
Chain A, Hyaluronidase, phage associatedStreptococcus pyogenes1000
UreaseCanavalia ensiformis (jack bean)8.59
Solute carrier family 23 member 1Homo sapiens (human)156

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolkenius, FN; Grisar, JM; Marciniak, G; Verne-Mismer, J; Wagner, ER1

Other Studies

1 other study(ies) available for mdl 73404 and ascorbic acid

ArticleYear
Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
    Journal of medicinal chemistry, 1995, Jul-21, Volume: 38, Issue:15

    Topics: Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Brain; Free Radical Scavengers; Lipid Peroxidation; Mice; Organophosphorus Compounds; Quaternary Ammonium Compounds; Rats; Stereoisomerism; Sulfonium Compounds; Superoxides; Vitamin E

1995